Cluster 2: Severe insulin-deficient diabetes.
Gestational diabetes was diabetes associated with pregnancy.
Diabetes is now divided into two major groups - Type-1 diabetes which accounts for around 10 per cent of the cases and Type-2 diabetes which accounts for 85-90 per cent of the cases.
People with diabetes have excessively high blood glucose, or blood sugar, which comes from food.
The results, published in The Lancet Diabetes and Endocrinology, showed the patients could be separated into five distinct clusters.
In their analysis of nearly 9000 patients with adult-onset diabetes, they identified five replicable clusters of disease, each with significantly different characteristics and risk of complications.
A patient in New Delhi is being administered with an insulin shot, a common diabetes treatment.
And each comes with significantly different characteristics and risk of complications, they found.
Based on these parameters the participants were classified into 5 groups.
Real's reliance on Ronaldo more evident than ever
Getafe found a way back into the game, however, after Nacho conceded a penalty for a foul on Jorge Molina . Real Madrid continued to press, though, and Ronaldo grabbed his second with 12 minutes remaining.
Still, the findings seem to be a positive step toward improved treatment of diabetes, which affects more than 420 million people worldwide.
Type 1 diabetes is a malady of the safe framework, which influences around 10% of individuals with the condition in the UK. Their BMI was low and they had poor metabolic control and deficiency of insulin. This group had the largest proportion of patients prescribed insulin (42%), as well as the shortest time to insulin use (HR 26.87 versus cluster 5, 95% CI 21.17-34.11).
In people with type 1 diabetes, which most often appears in childhood, the body can not make insulin - a hormone that helps glucose get into cells.
Cluster 2 had the highest risk of retinopathy, which can cause blindness.
The third cluster made up 15.3 percent of the whole cohort of participants.
Three in five women (59 per cent) and two in three men (68 per cent) are overweight or obese. This group had a low proportion of patients taking metformin, although the authors say they would be expected to benefit the most from the drug. Group 3 had the highest incidence of kidney damage - the secondary disease producing the highest costs to society. They also had a higher risk of nonalcoholic fatty liver disease. Clusters 3 and 4 can be thought of as falling between the two extremes. They were usually older adults and their metabolic profiles were not as bad as the others. One corresponded to type 1 diabetes and the other 4 were subtypes of type 2 diabetes.
The scientists from Lund University Diabetes Centre and Skåne University Hospital in Malmö, Sweden, and the Institute for Molecular Medicine, Helsinki, Finland, analysed 5 studies involving 14,775 adults from Sweden and Finland who had recently been diagnosed with diabetes.
Dr. Victoria Salem, a consultant and clinical scientist at Imperial College London, told the BBC that the study was a step forward for diabetes treatment but that it wouldn't lead to a change in practice just yet.
Rob Sladek, MD, of McGill University, Montral, wrote an accompanying editorial with this landmark paper.